SCHEMBL7941747

SCHEMBL7941747

C#CCCc1ccsc1C(C)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.39
MAPK10 P53779 1/20 0.39
NPSR1 Q6W5P4 2/20 0.36
PRNP P04156 1/20 0.36
PPARG P37231 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
NCOR2 Q9Y618 1/20 0.36
GSK3B P49841 1/20 0.34
PYCR1 P32322 1/20 0.34
KDM4E B2RXH2 3/20 0.34
MITF O75030 1/20 0.33
ABCC1 P33527 1/20 0.33
G6PD P11413 1/20 0.32
KMT2A Q03164 2/20 0.32
LMNA P02545 1/20 0.31
RAB9A P51151 1/20 0.31
LTB4R Q15722 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28898181 0.83 KMT2A (0.48) MAPK8MAPK10NPSR1RXFP1KDM4E
SCHEMBL12948208 0.79 PRKCI (0.43) MAPK8MAPK10NPSR1PRNPPPARG
SCHEMBL14614093 0.76 MAPK8 (0.42) MAPK8MAPK10NPSR1PRNPPPARG
SCHEMBL18599007 0.76 TYR (0.41) MAPK8MAPK10LTB4RALDH1A1GAA
SCHEMBL2080157 0.74 MAPK8 (0.41) MAPK8MAPK10NPSR1PRNPPPARG
SCHEMBL2083788 0.74 MAPK8 (0.41) MAPK8MAPK10NPSR1PRNPPPARG
SCHEMBL16807890 0.73 MAPK8 (0.52) MAPK8MAPK10NPSR1PRNPPPARG
SCHEMBL9093537 0.73 KDM4E (0.39) MAPK8MAPK10NPSR1PRNPPPARG
SCHEMBL15895178 0.73 GSK3B (0.43) MAPK8MAPK10NPSR1PRNPPPARG
SCHEMBL7546589 0.73 MAPK8 (0.41) MAPK8MAPK10NPSR1PRNPPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010054278-A2 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2010-05-14 WO disclosed